However, inhibition of ERK phosphorylation by administration of MAPK inhibitor prior to ischemia (in both global brain ischemia and MCAO model) decreased cell injury, infarct volume, and neurological deficit (Kindy, 1993; Wang et al., 2003; Castañeda et al., 2009). This evidence concerns the gene MAPK1 and brain ischemia.